US2017354821A1PendingUtilityA1

Modulation of autonomic nervous system activity and integrated electrode assemblies for trigeminal neurostimulation

48
Assignee: NEUROSIGMA INCPriority: Apr 24, 2013Filed: Aug 14, 2017Published: Dec 14, 2017
Est. expiryApr 24, 2033(~6.8 yrs left)· nominal 20-yr term from priority
A61N 1/36114A61N 1/0456A61N 1/36025A61N 1/36034A61N 1/36107A61N 1/0551A61N 1/36096A61N 1/36014
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Cutaneous and subcutaneous TNS embodiments are disclosed for addressing autonomic nervous system imbalances. A cutaneous electrode assembly is applied to a patient's forehead, and a current is pulsed through the electrode assembly to stimulate the supraorbital and supratrochlear nerves on the patient to increase activity for the patient's parasympathetic nervous system. Pulsing the current increases the power spectral density for the patient's heart rate variability in a 0.1 to 0.15 Hz frequency band.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method, comprising
 applying a cutaneous electrode assembly to a patient's forehead; and   pulsing current through the electrode assembly to stimulate the supraorbital and supratrochlear nerves on the patient to increase activity for the patient's parasympathetic nervous system.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.